Home/Filings/4/0001753926-25-001077
4//SEC Filing

Francis Knuettel II 4

Accession 0001753926-25-001077

CIK 0001919246other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 9:04 PM ET

Size

12.1 KB

Accession

0001753926-25-001077

Insider Transaction Report

Form 4
Period: 2025-07-01
Francis Knuettel II
CFO, Treas & Secty
Transactions
  • Other

    Series A Convertible Preferred Stock

    2025-07-01+10,00010,000 total(indirect: See footnote)
    Exercise: $10.00Common Stock (10,000 underlying)
  • Conversion

    Common Stock

    2025-07-01$10.00/sh+10,000$100,00010,000 total(indirect: By LLC)
  • Conversion

    Series A Convertible Preferred Stock

    2025-07-0110,0000 total(indirect: See footnote)
    Exercise: $10.00Common Stock (10,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    12,816
Footnotes (4)
  • [F1]The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.
  • [F2]Francis Knuettel II is the manager of Camden Capital LLC ("Camden") and the co-trustee of the Lara Knuettel Revocable Trust (the "Trust"). By virtue of these relationships, Mr. Knuettel may be deemed to beneficially own the shares of Common Stock held of record by each of Camden and the Trust. Mr. Knuettel disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
  • [F3]The Series A convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date. The Series A convertible preferred stock is subject to a contractual limitation such that the holder may not convert Series A convertible preferred stock to the extent that after giving effect to such conversion, the holder (together with its attribution parties as defined in the certificate of designations) would beneficially own in excess of 4.99% of the shares of common stock outstanding immediately after giving effect to such conversion.
  • [F4]Acquired in connection with cancellation of promissory note.

Documents

1 file

Issuer

Pelthos Therapeutics Inc.

CIK 0001919246

Entity typeother

Related Parties

1
  • filerCIK 0001433316

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 9:04 PM ET
Size
12.1 KB